The Signal Journal
Back

Tag

bayer

Supreme Court Limits Roundup Cancer Lawsuit Claims

The US Supreme Court has scaled back cancer lawsuits against Bayer's Roundup weedkiller, limiting state-level failure-to-warn claims that more than 100,000 plaintiffs had filed. The ruling reduces Bayer's legal exposure significantly and narrows the main legal theory driving mass Roundup litigation.

Supreme Court Backs Bayer, Blocks Roundup Cancer Lawsuits

The U.S. Supreme Court ruled for Bayer on Thursday, blocking thousands of state-law failure-to-warn lawsuits over Roundup's alleged cancer risk. The decision removes the main legal theory behind billions of dollars in prior verdicts and sharply reduces Bayer's future litigation exposure.

Judge Rejects Bayer Bid to Block J&J Erleada Ads

Judge Dale Ho in Manhattan denied Bayer's request to block Johnson & Johnson's advertising claiming Erleada cuts prostate cancer mortality risk by 51%, finding Bayer unlikely to prevail on its false advertising claims. The ruling leaves J&J's marketing campaign intact while the underlying lawsuit continues. Nubeqa and

AWS Launches Amazon Bio Discovery for AI Drug Design

AWS launched Amazon Bio Discovery, an AI platform enabling researchers to design and evaluate drug molecules without writing code. The service integrates biological foundation models, lab partner routing, and automated result feedback, compressing months of early-stage work into weeks. Bayer, the Broad Institute, and V

← Back

Tag

bayer

US Supreme Court scales back Roundup cancer lawsuits in victory for company

The US Supreme Court has scaled back cancer lawsuits against Bayer's Roundup weedkiller, limiting state-level failure-to-warn claims that more than 100,000 plaintiffs had filed. The ruling reduces Bayer's legal exposure significantly and narrows the main legal theory driving mass Roundup litigation.

1mo ago · 4 min · Global Affairs

Amazon Enters Drug Discovery Race with AI Platform for Faster Molecule Design

AWS launched Amazon Bio Discovery, an AI platform enabling researchers to design and evaluate drug molecules without writing code. The service integrates biological foundation models, lab partner routing, and automated result feedback, compressing months of early-stage work into weeks. Bayer, the Broad Institute, and V

4mo ago · 1 min · Technology

— End of feed —